$408.84-5.51% · 3M
Moving avg
1W-1.09%
1M+7.92%
3M-3.35%
6M-24.33%
YTD-13.08%
1Y+3.86%
3Y+50.92%
5Y+65.99%
52-week range
$331.6134% of range$556.52
Company health
Value5/6
Growth3/6
Profitability3/6
Health3/6
Dividend4/6
Bull vs bear
Strengths
- Reasonably valued at 12.8x earnings
- Analysts see 18% upside to a $482 target
- Analyst consensus is "Buy"
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$88.51B
Enterprise value
$132.55B
P/E ratio (TTM)
12.76x
P/S ratio (TTM)
1.09x
EV/EBITDA
8.37x
Per share & returns
EPS (TTM)
$30.70
Dividend yield
0.78%
Beta (1Y)
1.13
30-day change
+7.92%
Trading
Volume (24h)
468.18K
Previous close
$414.59
Shares outstanding
216.50M
About HCA Healthcare, Inc.
Sector
Healthcare
Industry
Medical - Care Facilities
Exchange
NYSE
Symbol
HCA
HCA Healthcare, Inc. is a large-cap healthcare company in the Medical - Care Facilities industry. Its shares are listed on NYSE (United States) and trade under the ticker HCA.
Frequently asked questions
What is HCA Healthcare, Inc.'s market cap?
HCA Healthcare, Inc. (HCA) has a market capitalization of $88.51B.
What is HCA Healthcare, Inc.'s P/E ratio?
HCA Healthcare, Inc. trades at a price-to-earnings (P/E) ratio of 12.76.
What exchange does HCA trade on?
HCA trades on NYSE.
Appears in
Eli Lilly and CompanyLLY
$1,217.61-0.22%
$1.15T cap
Johnson & JohnsonJNJ
$261.48+0.24%
$630.14B cap
AbbVie Inc.ABBV
$250.93+0.87%
$443.33B cap
UnitedHealth Group IncorporatedUNH
$402.36-0.80%
$365.40B cap
Roche Holding AGSWX: ROP
CHF 362.30-0.88%
$354.73B cap
Merck & Co., Inc.MRK
$134.62+1.28%
$332.49B cap
Novartis AGSWX: NOVN
CHF 123.74-0.37%
$289.30B cap
AstraZeneca PLCLON: AZN
£117.08+0.05%
$245.01B cap